Gujarat Themis Biosyn Ltd
BSE:506879
Gujarat Themis Biosyn Ltd
BSE:506879
Price:
402.3 INR
0.95%
Market Closed
Updated:
May 14, 2024
Gujarat Themis Biosyn Ltd
Operating Expenses
|
Gujarat Themis Biosyn Ltd
Operating Expenses Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
M
MANKIND
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gujarat Themis Biosyn Ltd
BSE:506879
|
Operating Expenses
-₹257m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-12%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Operating Expenses
-₹129.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Operating Expenses
-₹114.8B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-10%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Operating Expenses
-₹267.7B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-16%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Operating Expenses
-₹84.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-10%
|
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
Operating Expenses
-₹40.9B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gujarat Themis Biosyn Ltd's Operating Expenses?
Operating Expenses
-257m
INR
-257m
INR
Based on the financial report for Dec 31, 2023, Gujarat Themis Biosyn Ltd's Operating Expenses amounts to -257m INR.
What is Gujarat Themis Biosyn Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-12%
-12%
Over the last year, the Operating Expenses growth was 44%. The average annual Operating Expenses growth rates for Gujarat Themis Biosyn Ltd have been 15% over the past three years , -20% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
